Skip to main content
. 2020 Feb 7;65(8):568–576. doi: 10.1177/0706743720904613

Table 1.

Utility and Efficacy Parameters.

Parameter Value (SD) Distribution Source
Utilities
 Remission, no maintenance treatment 0.86 (0.16) Beta Revicki and Wood36
 Relapse, no maintenance treatment 0.33 (0.25) Beta Sapin et al.37
 MBCT adherence, relapse into depressive episode 0.48 (0.05) Beta Koeser et al.38
 ADM adherence, relapse into depressive episode 0.58 (0.28) Beta Sapin et al.37
 MBCT adherence, no relapse 0.80 (0.02) Beta Koeser et al.38
 ADM adherence, no relapse 0.85 (0.13) Beta Sapin et al.37
Probabilities
 Adherence, MBCT 0.83 (0.166) Beta Kuyken et al.23
 Adherence, ADM 0.45 (0.09) Beta Composite of Klein et al.39, ten Doesschate et al.13, Sheehan et al.40, and Akincigil et al.41
 Relapse, 12 months, MBCT 0.44 (0.11) Beta Piet and Houggard42
 Relapse, 12 months, ADM 0.48 (0.12) Beta Piet and Houggard42
 Relapse, 24 months, MBCT 0.44 (0.11) Beta Kuyken et al.23
 Relapse, 24 months, ADM 0.47 (0.118) Beta Kuyken et al.23
 Relapse, nonadherence 0.80 (0.2) Beta Frank et al.43

Note. Adherence SE based on assumption of ± 20% and relapse (MBCT, ADM) SE based on assumption of ± 25%. ADM = antidepressant medication; MBCT = mindfulness-based cognitive therapy.